Lung Adenocarcinoma : EGFR Amplification and Mutation Analysis

Test Information

For Lung Adenocarcinoma, GGC offers amplification and mutation analysis of EGFR exons 18-21

Turnaround Time

10 days

CPT Code(s)

81406

Cost

$1,000

Genes

Clinical Information

EGFR Amplification and Mutation Analysis: Mutations in exons 18-21 of epidermal growth factor receptor (EGFR), for example, are reported to provide valuable information on sensitivity to EGFR inhibitors. These mutations occur in around 10% of all lung adenocarcinomas with estimates of up to 40% in some Asian cohorts (BMC Pulmonary Medicine (2016) 16(1):88). The predictive information afforded by EGFR mutational testing in exons 18-21 has led NCCN to recommend patients diagnosed with non-squamous NSCLC or NSCLC not otherwise specified have EGFR mutation testing.

Indications

Gene sequencing and targeted mutation testing and copy number analysis can serve as a useful diagnostic and potentially prognostic tool for the analysis of affected tissues or tumors. The detection of copy number variants or specific gene mutations may enhance treatment decisions.

Specimen Requirements

Analysis can be performed on fresh or frozen tissue samples as well as formalin-fixed, paraffin-embedded tissue samples.

Transport Instructions

The specimen should be kept at the appropriate temperature and delivered via overnight shipping.

Have Questions Need Support?

Call our laboratory at 1-800-473-9411 or contact one of our Laboratory Genetic Counselors for assistance.
Robin Fletcher, MS, CGC
Kellie Walden, MS, CGC

Oncology Testing, Targeted Variants
Meet Reggie Roper

Meet Reggie Roper

Reggie has been part of the GGC family for over 18 years. He has short stature, webbing of his hands, pulmonary stenosis, seizures and hydrocephalus along with developmental delay. He carried an initial diagnosis of cardiofaciocutaneous (CFC) syndrome; however, as genetic testing advanced, GGC made the diagnosis of Noonan-like syndrome with loose anagen hair by identifying a mutation in the SHOC2 gene. He is also an active participant in the Greenwood Community Theatre's Penguin Project. "GGC is...

In The News